CBI plants presence in Japan
Commonwealth Biotechnologies (CBI) has planted its first roots in Japan, as the world's number two pharmaceutical market continues to attract foreign firms.
Commonwealth Biotechnologies (CBI) has planted its first roots in Japan, as the world's number two pharmaceutical market continues to attract foreign firms.
Outsourcing-Pharma.com presents a round-up of recent contracts signed in the manufacturing arena, featuring new deals for Angel Biotechnology, PharmEng and Akela Pharma.
Eli Lilly and Rexam are both investing in their French manufacturing facilities in preparation for the production of an insulin pen they are developing.
Ireland's Almac Group has announced the creation of a new oncology division that will focus on the discovery and development of "novel and innovative" approaches to treatment in this key disease area.